Pierre Giglio to Glioma
This is a "connection" page, showing publications Pierre Giglio has written about Glioma.
Connection Strength
1.652
-
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 2012 Jul 15; 118(14):3599-606.
Score: 0.354
-
Cyclooxygenase-2 inhibitors in glioma therapy. Am J Ther. 2004 Mar-Apr; 11(2):141-3.
Score: 0.208
-
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin Cancer Res. 2022 06 01; 28(11):2270-2277.
Score: 0.184
-
Management of gliomas in patients with Lynch syndrome. Neuro Oncol. 2021 01 30; 23(1):167-168.
Score: 0.168
-
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
Score: 0.167
-
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.
Score: 0.165
-
Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Rev Neurother. 2019 07; 19(7):663-677.
Score: 0.149
-
Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade. Clin Imaging. 2018 Nov - Dec; 52:88-94.
Score: 0.140
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.073
-
Intraoperative 3?T MRI is more correlative to residual disease extent than early postoperative MRI. J Neurooncol. 2021 Sep; 154(3):345-351.
Score: 0.044